ATH 0.00% 0.5¢ alterity therapeutics limited

cognition and function

  1. 10 Posts.
    Most of the discussion seems to be based on the Pib-PET results, particularly in regard to the placebo results but the report also states "No improvement was observed on the secondary endpoints of brain metabolic activity,cognition and function;"

    I am positive re Prana and, in fact bought more on Tuesday but this seems to be a very important outcome. One would have hoped that cognition and function would have shown "some" improvement. Perhaps Prana are still analysing the data themselves.

    What do others think?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $1.187K 237.4K

Buyers (Bids)

No. Vol. Price($)
47 43073866 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20762393 18
View Market Depth
Last trade - 11.46am 16/05/2024 (20 minute delay) ?
Last
0.6¢
  Change
0.000 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 560000
Last updated 12.03pm 16/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.